hpn217
abbvie
['congrat', 'hpn217']
$harp currently +86%! interim ph1 results from hpn217 trial in r/r mm presented at #ash22 on sunday congrats to the 2 hedge funds holding $harp at the end of q3: bioimpact capital
orbimed get the full q3 hedge fund report! $xbi 1.9%
$ibb 0%
FDA Catalyst Calendar, Big Mover™ stocks to watch, & Model Portfolios. Database & tools to make you a profitable biotech stock investor. Try Free https://t.co/5njnanr11i